May Han

May Han General Information

Biography

Dr. May Han serves as Partner at Cure Ventures. She worked at Millennium Pharmaceuticals, AVEO, and Novartis in positions of increasing responsibility targeting different disease areas. She served as a Team Leader, Global Project Manager, and Director roles while at the Novartis Institute of Biomedical Research. At Novartis, she led 20 drug discovery programs and a hematologic cancer portfolio as program manager. Additionally, she supervised a large group of experienced drug developers with over 100 years of drug development experience, who manage a large portfolio of over 30 complex clinical-stage programs. She served as a Program Leader, Director at AVEO, she led an antibody program from inception to completion of a randomized Phase 2 study with hands-on experience in nearly all aspects of drug development. She led multiple biotech-pharma collaborations from both biotech and pharma sides, with transactions in excess of $1 billion dollars. She holds a Ph.D. in Molecular Biophysics and Biochemistry from Yale University, B.S. in Biochemistry from Beijing University, PR China. Prior to joining the pharmaceutical industry, she was a CH Revson Fellow at Rockefeller University in the lab of Dr. Thomas Sakmar and an HH Whitney fellow at Yale in the lab of Dr. Paul Sigler.